Correlation between different intensities of anti-vitamin K treatment and coagulation parameters

被引:13
作者
Jerkeman, A
Astermark, J
Hedner, U
Lethagen, S
Olsson, CG
Berntorp, E [1 ]
机构
[1] Malmo Univ Hosp, Dept Coagulat Disorders, SE-20502 Malmo, Sweden
[2] Univ Lund Hosp, Dept Med, S-22185 Lund, Sweden
关键词
warfarin; coagulation factors; venous thrombosis; thrombin generation; anticoagulation; antivitamin K;
D O I
10.1016/S0049-3848(00)00203-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In order to study the effect of different intensities of anti-vitamin K treatment on coagulation parameters, 23 patients with venous thromboembolism were given, after the initial treatment period, warfarin at doses giving an International Normalised Ratio of 1.3-2.0 for 4 weeks, and of 1.1-1.3 for another 4 weeks. Blood samples were taken at the end of each of these periods and 4 weeks after the end of warfarin treatment. The vitamin K-dependent coagulation factors VII, IX, and X, as well as the inhibitor protein C and its cofactor protein S, all showed a highly significant correlation with treatment intensity. This was to some extent also true for the coagulation activation markers, prothrombin fragment 1 + 2 and thrombin-antithrombin complex. Ratios of pro- and anticoagulant factors in some instances showed a decrease at therapeutical (International Normalised Ratio) levels, and also sometimes with reduced warfarin treatment intensity. Taken together, our results encourage further research addressing issues of varying treatment intensity with warfarin and alternative methods for monitoring of anti-vitamin K treatment. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:467 / 471
页数:5
相关论文
共 18 条
[1]  
BARARIT DW, 1960, LANCET, V1, P1309
[2]   Are prothrombin fragment 1+2 and thrombin-antithrombin complexes useful in the management of oral anticoagulant therapy? [J].
Barcellona, D ;
Biondi, G ;
Mameli, G ;
Marongiu, F .
INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1997, 27 (01) :76-78
[3]  
BAUER KA, 1989, BLOOD, V74, P2007
[4]   ACENOCOUMAROL AND HEPARIN COMPARED WITH ACENOCOUMAROL ALONE IN THE INITIAL TREATMENT OF PROXIMAL-VEIN THROMBOSIS [J].
BRANDJES, DPM ;
HEIJBOER, H ;
BULLER, HR ;
DERIJK, M ;
JAGT, H ;
TENCATE, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1485-1489
[5]   SUPPRESSION OF HEMOSTATIC SYSTEM ACTIVATION BY ORAL ANTICOAGULANTS IN THE BLOOD OF PATIENTS WITH THROMBOTIC DIATHESES [J].
CONWAY, EM ;
BAUER, KA ;
BARZEGAR, S ;
ROSENBERG, RD .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (06) :1535-1544
[6]   ASSESSMENT OF ANTICOAGULANT TREATMENT OF VENOUS THROMBOEMBOLISM [J].
COON, WW ;
WILLIS, PW ;
SYMONS, MJ .
ANNALS OF SURGERY, 1969, 170 (04) :559-&
[7]   LOW-DOSE WARFARIN DECREASES COAGULABILITY WITHOUT AFFECTING PROTHROMBIN COMPLEX ACTIVITY [J].
HOLM, J ;
BERNTORP, E ;
CARLSSON, R ;
ERHARDT, L .
JOURNAL OF INTERNAL MEDICINE, 1993, 234 (03) :303-308
[8]  
HULL R, 1979, NEW ENGL J MED, V301, P855, DOI 10.1056/NEJM197910183011602
[9]   DIFFERENT INTENSITIES OF ORAL ANTICOAGULANT-THERAPY IN THE TREATMENT OF PROXIMAL-VEIN THROMBOSIS [J].
HULL, R ;
HIRSH, J ;
JAY, R ;
CARTER, C ;
ENGLAND, C ;
GENT, M ;
TURPIE, AGG ;
MCLOUGHLIN, D ;
DODD, P ;
THOMAS, M ;
RASKOB, G ;
OCKELFORD, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (27) :1676-1681
[10]   A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism [J].
Kearon, C ;
Gent, M ;
Hirsh, J ;
Weitz, J ;
Kovacs, MJ ;
Anderson, DR ;
Turpie, AG ;
Green, D ;
Ginsberg, JS ;
Wells, P ;
MacKinnon, B ;
Julian, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (12) :901-907